Indian students eyeing New Zealand education now face significantly longer visa waits, with processing times nearly doubling compared to la...

US Homeland Security is proposing a significant hike in naturalisation application fees, with Form N-400 potentially rising by 75% to $1,33...

A US court blocked a $100,000 H-1B visa fee, deeming it an unconstitutional tax imposed by presidential authority without congressional app...

US authorities are set to replace the 'duration of status' system for international students with fixed stay periods. This significant poli...

New research has revealed that deep sleep isn't just for rest; it actively regulates growth hormone, crucial for muscle repair, bone streng...

More sleep means good health? Answer is no. Study says people with diabetes face risk of developing deadly liver disease with rise in nap t...

New Zealand is updating its skilled migrant and work-to-residence visa programs. New rules begin August 24, 2026. Wage thresholds are simpl...

Qatar has cut the exit window for foreign workers after residence permit cancellation to just two weeks. Previously, workers had 30 days to...

Christian Bale's humorous confession about his love for sleep, even admitting to wanting 12 hours daily, offers a relatable human touch. Be...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Cipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...